News: Mylan accused Teva for Trust Violation $MYL
Mylan NV, has accused Teva Pharmaceutical Industries Ltd. for the Violation of U.S. Anti-trust Rules, in an acquisition deal. Teva disclosed a 1.35 percent stake in Mylan last week. Furthermore, The violated rule is not yet clarified by Mylan. View the full release here.
News: Mylan accused Teva for Trust Violation $MYL Read More »